Halozyme Therapeutics Inc : Benchmark Raises Target Price to $60 From $50
Halozyme Therapeutics Inc : Benchmark 將目標價從$50上調至$60
Halozyme Therapeutics Inc : Benchmark Raises Target Price to $60 From $50
Halozyme Therapeutics Inc : Benchmark 將目標價從$50上調至$60
譯文內容由第三人軟體翻譯。